61 results
Page 2 of 4
8-K
EX-99.1
cvyqcg 3gh
3 Nov 21
Arvinas Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
8-K
EX-99.1
c8yeih619oeo8yn1yx
5 Aug 21
Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:02pm
8-K
EX-10.1
9v9s1 yj0tip
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
DEFA14A
p5bzu
26 Apr 21
Additional proxy soliciting materials
4:22pm
8-K
EX-99.1
vm547xn7n73iwnay9
1 Mar 21
Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:03pm
424B5
esudl9h9utpg2p
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
k2a hxxo7xa08mh3
14 Dec 20
Prospectus supplement for primary offering
4:48pm
8-K
EX-99.1
vkn8xg3wjk
5 Nov 20
Arvinas Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:31am
8-K
EX-99.1
zpoh0wsjfq64vi8rlw8
4 Aug 20
Arvinas Reports Second Quarter 2020 Financial Results and Provides Corporate Update
4:47pm
DEFA14A
6d7e9578
20 May 20
Additional proxy soliciting materials
4:59pm
8-K
EX-99.1
5v0b5e2
28 Apr 20
Arvinas Reports First Quarter 2020 Financial Results and Provides a Corporate Update
4:59pm
DEFA14A
x8pvyamiixhxau
21 Apr 20
Additional proxy soliciting materials
5:05pm